Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (550)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
148
2025
3049
8.950
Why?
Hematopoietic Stem Cell Transplantation
28
2024
606
3.470
Why?
Pyrazines
20
2023
190
2.600
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
1031
2.440
Why?
Boronic Acids
19
2014
183
2.410
Why?
Thalidomide
28
2023
377
2.390
Why?
Transplantation, Autologous
30
2024
488
1.910
Why?
Antineoplastic Agents
30
2020
1222
1.890
Why?
Transplantation Conditioning
9
2019
93
1.430
Why?
Drug Resistance, Neoplasm
17
2020
327
1.420
Why?
Paraproteinemias
8
2018
74
1.250
Why?
Neoplastic Stem Cells
5
2020
93
1.170
Why?
Humans
158
2025
52336
1.160
Why?
Protease Inhibitors
6
2011
61
1.050
Why?
Venous Thrombosis
7
2009
90
1.020
Why?
Melphalan
16
2023
181
0.980
Why?
Stem Cell Transplantation
13
2023
185
0.980
Why?
Angiogenesis Inhibitors
9
2009
183
0.970
Why?
Plasma Cells
12
2025
239
0.960
Why?
Aged
59
2025
10109
0.940
Why?
Prognosis
34
2025
2094
0.930
Why?
Gene Expression Regulation, Neoplastic
13
2020
858
0.920
Why?
Hematopoietic Stem Cell Mobilization
5
2014
60
0.920
Why?
Middle Aged
61
2025
13014
0.880
Why?
Alkaline Phosphatase
5
2011
94
0.830
Why?
Busulfan
3
2019
17
0.830
Why?
Treatment Outcome
39
2022
5407
0.770
Why?
Dexamethasone
16
2024
440
0.730
Why?
Male
69
2025
26696
0.690
Why?
Chromosome Aberrations
9
2008
297
0.650
Why?
Female
65
2025
28105
0.650
Why?
Thromboembolism
3
2009
50
0.640
Why?
Neoplasm Proteins
6
2021
334
0.610
Why?
Chromosomes, Human, Pair 13
6
2008
38
0.590
Why?
Gene Expression Profiling
19
2025
1110
0.570
Why?
Disease-Free Survival
14
2019
460
0.560
Why?
Immunoglobulin Light Chains
3
2016
90
0.550
Why?
Survival Rate
18
2019
940
0.550
Why?
Bone Remodeling
2
2010
154
0.550
Why?
Anticoagulants
5
2009
267
0.550
Why?
Blood Transfusion
1
2018
128
0.540
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
125
0.540
Why?
Immunologic Factors
5
2012
117
0.540
Why?
Cell Line, Tumor
18
2023
1436
0.510
Why?
Follow-Up Studies
21
2024
2268
0.500
Why?
Receptors, Retinoic Acid
2
2013
22
0.500
Why?
Antineoplastic Agents, Alkylating
7
2008
77
0.490
Why?
Proteasome Inhibitors
6
2018
105
0.490
Why?
Adult
39
2025
14139
0.490
Why?
IMP Dehydrogenase
2
2006
3
0.490
Why?
Mycophenolic Acid
2
2006
19
0.480
Why?
Clinical Trials as Topic
9
2022
468
0.480
Why?
Combined Modality Therapy
13
2008
636
0.470
Why?
Disease Progression
13
2025
870
0.460
Why?
Recurrence
16
2018
672
0.460
Why?
Cell Proliferation
15
2020
1029
0.460
Why?
Retrospective Studies
19
2025
6578
0.450
Why?
Antigens, Neoplasm
5
2007
147
0.450
Why?
Apoptosis
9
2019
1127
0.440
Why?
Up-Regulation
5
2020
462
0.440
Why?
Antibodies, Monoclonal
3
2015
481
0.440
Why?
Osteogenesis
3
2012
366
0.430
Why?
Animals
30
2024
13523
0.430
Why?
Venous Thromboembolism
3
2011
75
0.420
Why?
Survival Analysis
12
2021
671
0.420
Why?
Doxorubicin
8
2018
239
0.420
Why?
Signal Transduction
12
2020
1716
0.410
Why?
Bone Diseases
3
2012
95
0.410
Why?
Neoplasms, Second Primary
2
2024
77
0.400
Why?
Thrombosis
4
2012
253
0.390
Why?
T-Lymphocytes
10
2024
340
0.390
Why?
Central Nervous System Neoplasms
2
2004
69
0.380
Why?
Myeloablative Agonists
5
2014
32
0.380
Why?
Bone Marrow
7
2022
364
0.380
Why?
Oligopeptides
2
2013
93
0.370
Why?
Transplantation, Homologous
6
2004
150
0.370
Why?
Osteoblasts
4
2007
475
0.360
Why?
Hematopoietic Stem Cells
2
2010
188
0.360
Why?
Risk Factors
18
2018
3872
0.360
Why?
Meta-Analysis as Topic
2
2015
40
0.350
Why?
Salvage Therapy
9
2012
136
0.350
Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.350
Why?
Tumor Microenvironment
3
2024
255
0.340
Why?
Bone Marrow Transplantation
5
2007
113
0.340
Why?
Mice
19
2024
5965
0.340
Why?
Enzyme Inhibitors
2
2019
374
0.330
Why?
Membrane Proteins
4
2017
340
0.330
Why?
Ultrasonography, Doppler
2
2007
42
0.330
Why?
Remission Induction
10
2008
218
0.320
Why?
Prospective Studies
9
2019
2428
0.320
Why?
Cell Cycle Proteins
2
2021
173
0.320
Why?
Neoplasm, Residual
4
2022
173
0.320
Why?
Myelodysplastic Syndromes
4
2007
86
0.310
Why?
B-Lymphocytes
4
2021
185
0.310
Why?
Aged, 80 and over
12
2025
3391
0.300
Why?
Waldenstrom Macroglobulinemia
3
2018
40
0.300
Why?
Lymphoma, B-Cell
3
2021
61
0.300
Why?
Neovascularization, Pathologic
1
2009
158
0.300
Why?
Immunosuppressive Agents
3
2005
243
0.300
Why?
Bone Neoplasms
1
2010
184
0.290
Why?
Killer Cells, Natural
4
2024
116
0.280
Why?
Brain Diseases, Metabolic
1
2007
5
0.280
Why?
Dose-Response Relationship, Drug
6
2016
1377
0.270
Why?
Chromosome Deletion
3
2008
142
0.270
Why?
Hyperammonemia
1
2007
24
0.270
Why?
Proteasome Endopeptidase Complex
4
2018
141
0.270
Why?
Amyloidosis
2
2007
85
0.270
Why?
Farnesyltranstransferase
1
2006
4
0.270
Why?
Research Design
1
2009
354
0.270
Why?
Thrombophilia
4
2009
19
0.270
Why?
Small Molecule Libraries
2
2019
67
0.270
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
59
0.270
Why?
Hemostasis
1
2007
60
0.260
Why?
Bone and Bones
1
2010
494
0.260
Why?
Flow Cytometry
6
2018
404
0.260
Why?
Sirolimus
1
2006
67
0.250
Why?
Cell Survival
8
2018
602
0.250
Why?
Gastrointestinal Neoplasms
1
2006
42
0.250
Why?
Immunotherapy, Adoptive
4
2024
167
0.250
Why?
Caspases
1
2006
105
0.240
Why?
In Situ Hybridization, Fluorescence
6
2016
263
0.240
Why?
Diploidy
2
2004
25
0.240
Why?
beta 2-Microglobulin
5
2008
39
0.240
Why?
Antibody Formation
1
2005
51
0.230
Why?
Religion
1
2005
61
0.230
Why?
Activated Protein C Resistance
4
2011
10
0.230
Why?
Case-Control Studies
10
2018
1201
0.230
Why?
Aneuploidy
1
2004
18
0.220
Why?
Enoxaparin
1
2004
30
0.220
Why?
Attitude to Health
1
2005
192
0.220
Why?
Ubiquitination
2
2021
57
0.220
Why?
Adaptation, Psychological
1
2005
229
0.210
Why?
Osteolysis
2
2022
75
0.210
Why?
Multivariate Analysis
5
2008
590
0.210
Why?
Cancer Vaccines
3
2010
78
0.210
Why?
Cisplatin
6
2009
285
0.210
Why?
Pyrimidines
3
2015
199
0.210
Why?
Cell Communication
2
2006
72
0.200
Why?
Randomized Controlled Trials as Topic
4
2012
594
0.200
Why?
Blood Coagulation
1
2003
60
0.200
Why?
Critical Illness
1
2005
292
0.200
Why?
Mice, Inbred NOD
6
2020
92
0.200
Why?
Antigens, CD34
1
2003
73
0.200
Why?
Cytogenetic Analysis
6
2007
80
0.200
Why?
Parathyroid Hormone
3
2010
149
0.190
Why?
Graft vs Host Disease
5
2010
88
0.190
Why?
Cyclophosphamide
4
2003
171
0.190
Why?
Leukemia, Myeloid
1
2002
42
0.190
Why?
STAT3 Transcription Factor
4
2015
88
0.190
Why?
Bone Resorption
2
2022
302
0.190
Why?
Kidney
1
2007
708
0.190
Why?
Chromosome Disorders
1
2002
32
0.190
Why?
Etoposide
5
2009
72
0.190
Why?
Time Factors
9
2016
2957
0.190
Why?
Hypothyroidism
1
2002
57
0.180
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
68
0.180
Why?
Logistic Models
5
2018
920
0.180
Why?
Chromosomes, Human, Pair 1
3
2006
96
0.180
Why?
Antibodies, Bispecific
1
2022
94
0.170
Why?
Neoplasm Recurrence, Local
4
2024
643
0.170
Why?
Cytotoxicity, Immunologic
3
2012
58
0.170
Why?
Xenograft Model Antitumor Assays
5
2019
222
0.160
Why?
DNA-Binding Proteins
2
2020
429
0.160
Why?
Neoplasms
2
2009
1305
0.160
Why?
Glucuronidase
2
2018
47
0.160
Why?
Predictive Value of Tests
5
2009
943
0.160
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
129
0.160
Why?
Hematologic Neoplasms
2
2016
106
0.160
Why?
Osteoclasts
4
2022
428
0.150
Why?
Syndecan-1
3
2017
73
0.150
Why?
Cytokines
4
2007
625
0.150
Why?
Kaplan-Meier Estimate
6
2015
484
0.150
Why?
Hydrocarbons, Aromatic
1
2018
2
0.150
Why?
Healthcare Disparities
1
2022
299
0.150
Why?
Drug Tolerance
1
2018
60
0.150
Why?
Solvents
1
2018
33
0.150
Why?
T-Lymphocytes, Cytotoxic
3
2010
66
0.150
Why?
Pyridines
1
2019
133
0.150
Why?
Jehovah's Witnesses
1
2018
6
0.150
Why?
Dendritic Cells
3
2010
136
0.150
Why?
Vincristine
3
2003
88
0.150
Why?
Cell Differentiation
4
2022
674
0.140
Why?
Platelet Count
3
2008
75
0.140
Why?
CDC2-CDC28 Kinases
2
2015
11
0.140
Why?
Iron
2
2017
129
0.140
Why?
Risk Assessment
5
2023
1323
0.140
Why?
Occupational Diseases
1
2018
85
0.140
Why?
Arsenicals
2
2010
15
0.140
Why?
Pyruvate Kinase
1
2017
7
0.130
Why?
Interleukin-6
2
2018
278
0.130
Why?
Ascorbic Acid
1
2017
25
0.130
Why?
Drug Combinations
1
2017
134
0.130
Why?
Oxides
2
2010
21
0.130
Why?
Mice, SCID
5
2018
182
0.130
Why?
Occupational Exposure
1
2018
111
0.130
Why?
RNA Splicing
1
2017
41
0.130
Why?
Anthropometry
1
2017
101
0.130
Why?
Transcription Factors
1
2020
574
0.130
Why?
Glycolysis
1
2017
73
0.130
Why?
Immunotherapy
4
2006
244
0.130
Why?
Immunoglobulin lambda-Chains
1
2016
15
0.130
Why?
Factor V
3
2011
11
0.130
Why?
Immunoglobulin kappa-Chains
1
2016
22
0.130
Why?
Fibrinolytic Agents
2
2007
127
0.130
Why?
Tumor Cells, Cultured
6
2019
456
0.130
Why?
Incidence
3
2009
1059
0.130
Why?
Leukocytes, Mononuclear
2
2014
122
0.120
Why?
MicroRNAs
1
2020
387
0.120
Why?
Reproductive History
1
2015
4
0.120
Why?
Oncolytic Virotherapy
1
2015
21
0.120
Why?
Hormone Replacement Therapy
1
2015
21
0.120
Why?
Cyclopentanes
1
2015
12
0.120
Why?
Cell Adhesion Molecules
1
2015
87
0.120
Why?
Hemorrhage
2
2007
209
0.120
Why?
Ubiquitins
1
2015
40
0.120
Why?
Postmenopause
1
2015
82
0.120
Why?
Cation Transport Proteins
1
2015
27
0.120
Why?
Receptors, Cell Surface
1
2015
113
0.120
Why?
Aldehyde Dehydrogenase
1
2014
25
0.120
Why?
NF-kappa B
3
2018
328
0.120
Why?
Intestines
1
2016
154
0.110
Why?
Drug Monitoring
1
2015
83
0.110
Why?
Leukapheresis
1
2014
19
0.110
Why?
Protein-Tyrosine Kinases
1
2015
89
0.110
Why?
Translocation, Genetic
3
2005
265
0.110
Why?
Transplantation Chimera
3
2003
16
0.110
Why?
Myeloma Proteins
2
2020
26
0.110
Why?
Gene Deletion
3
2004
276
0.110
Why?
Antibodies
2
2024
152
0.110
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
25
0.110
Why?
Veratrum Alkaloids
1
2013
5
0.110
Why?
Polymorphism, Single Nucleotide
1
2016
506
0.110
Why?
Body Mass Index
1
2017
689
0.110
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.110
Why?
Isoxazoles
1
2013
15
0.110
Why?
Sulfones
1
2013
24
0.100
Why?
Biopsy
2
2006
604
0.100
Why?
Hedgehog Proteins
1
2013
34
0.100
Why?
Cystatin M
2
2024
19
0.100
Why?
Itraconazole
1
2013
38
0.100
Why?
Metaphase
3
2008
46
0.100
Why?
Genetic Predisposition to Disease
1
2016
528
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
62
0.100
Why?
Carrier Proteins
2
2017
326
0.100
Why?
Wnt Proteins
1
2013
102
0.100
Why?
B-Cell Maturation Antigen
2
2024
98
0.100
Why?
Renal Insufficiency
3
2009
113
0.100
Why?
Risk
2
2011
313
0.100
Why?
Infusions, Intravenous
2
2003
220
0.100
Why?
Viremia
1
2012
23
0.100
Why?
Drug Delivery Systems
2
2005
146
0.100
Why?
Chromosomes, Human, Pair 11
2
2002
55
0.100
Why?
Cytomegalovirus Infections
1
2012
36
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
47
0.090
Why?
Radiopharmaceuticals
2
2021
205
0.090
Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.090
Why?
Receptors, KIR
2
2008
12
0.090
Why?
Phosphorylation
2
2020
531
0.090
Why?
Fluorodeoxyglucose F18
2
2021
188
0.090
Why?
Medical Oncology
1
2012
104
0.090
Why?
Reoperation
2
2004
465
0.090
Why?
Ligands
2
2009
207
0.090
Why?
Drug Evaluation, Preclinical
1
2012
143
0.090
Why?
Alcohol Drinking
1
2013
236
0.090
Why?
Inflammation
1
2016
642
0.090
Why?
Age Factors
3
2005
1127
0.090
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
Why?
Smoking
1
2014
518
0.090
Why?
Tretinoin
2
2009
54
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Recombinant Proteins
2
2010
491
0.090
Why?
Janus Kinase 1
1
2010
16
0.080
Why?
Antineoplastic Agents, Hormonal
2
2007
53
0.080
Why?
Down-Regulation
2
2010
347
0.080
Why?
MAP Kinase Kinase 1
1
2010
23
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Macrophages
1
2013
378
0.080
Why?
Authorship
1
2010
12
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.080
Why?
Neoplasm Staging
3
2015
770
0.080
Why?
Bone Density Conservation Agents
1
2010
75
0.080
Why?
Conflict of Interest
1
2010
26
0.080
Why?
Drug Industry
1
2010
40
0.080
Why?
Disclosure
1
2010
41
0.080
Why?
Diphosphonates
1
2010
92
0.080
Why?
Mice, Transgenic
3
2021
563
0.080
Why?
Chromosome Banding
2
2006
24
0.080
Why?
Leukocyte Count
2
2014
73
0.080
Why?
Plasmacytoma
2
2011
43
0.080
Why?
Maximum Tolerated Dose
2
2009
39
0.080
Why?
Periodicals as Topic
1
2010
61
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
412
0.080
Why?
Cell Cycle
2
2010
240
0.080
Why?
Magnetic Resonance Imaging
3
2007
1543
0.080
Why?
Cryoglobulinemia
1
2008
13
0.080
Why?
Blotting, Western
3
2015
596
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
186
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Prednisone
2
2009
102
0.070
Why?
Pulmonary Embolism
1
2009
84
0.070
Why?
Polyethylene Glycols
1
2008
89
0.070
Why?
Sulfonamides
1
2009
133
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
583
0.070
Why?
Neutrophils
2
2014
146
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Immunophenotyping
2
2007
117
0.070
Why?
Hemoglobins
1
2008
110
0.070
Why?
Heparin, Low-Molecular-Weight
1
2007
21
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
132
0.070
Why?
Histocompatibility Antigens Class I
1
2007
48
0.070
Why?
Phlebography
1
2007
55
0.070
Why?
Fibrinolysis
1
2007
6
0.070
Why?
Blood Coagulation Factors
1
2007
18
0.070
Why?
Ammonia
1
2007
86
0.070
Why?
Serum Albumin
2
2008
58
0.070
Why?
Chi-Square Distribution
1
2007
288
0.070
Why?
Cell Membrane
1
2007
245
0.070
Why?
Biomedical Research
1
2010
256
0.070
Why?
Brain
2
2007
1323
0.060
Why?
Drug Administration Schedule
2
2006
372
0.060
Why?
Osteoprotegerin
1
2006
53
0.060
Why?
Models, Genetic
1
2006
172
0.060
Why?
Guanosine
1
2006
7
0.060
Why?
Antibiotics, Antineoplastic
1
2006
78
0.060
Why?
Sex Factors
3
2016
727
0.060
Why?
Femur Head Necrosis
1
2005
17
0.060
Why?
Renal Dialysis
1
2007
179
0.060
Why?
Survivors
1
2006
118
0.060
Why?
Guanosine Triphosphate
1
2004
17
0.060
Why?
Karyotyping
1
2005
78
0.060
Why?
Gene Duplication
1
2005
16
0.060
Why?
Neovascularization, Physiologic
1
2005
86
0.060
Why?
Oncogene Proteins, Fusion
1
2005
61
0.060
Why?
Tissue Donors
2
2003
126
0.060
Why?
ROC Curve
1
2025
251
0.060
Why?
Kidney Transplantation
1
2007
192
0.060
Why?
Proteolysis
2
2015
102
0.060
Why?
Thrombophlebitis
1
2004
18
0.060
Why?
Genomic Instability
1
2005
89
0.060
Why?
Tomography, Emission-Computed
1
2004
53
0.060
Why?
Ferritins
1
2024
36
0.050
Why?
Neoplastic Cells, Circulating
1
2004
34
0.050
Why?
RNA Interference
2
2015
186
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
Chromatography, High Pressure Liquid
1
2004
338
0.050
Why?
Patient Selection
1
2005
259
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Discitis
1
2003
10
0.050
Why?
Lymphocyte Transfusion
1
2003
10
0.050
Why?
Confidence Intervals
1
2003
158
0.050
Why?
Probability
1
2003
171
0.050
Why?
Interferons
1
2002
38
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
144
0.050
Why?
Anxiety
1
2005
300
0.050
Why?
Cyclosporine
1
2003
67
0.050
Why?
Drug Therapy, Combination
2
2017
395
0.050
Why?
Transcriptome
1
2025
367
0.050
Why?
Geography
1
2022
66
0.050
Why?
Thyroid Function Tests
1
2002
27
0.050
Why?
Blood Group Incompatibility
1
2002
4
0.050
Why?
Tacrolimus
1
2003
60
0.050
Why?
Stromal Cells
1
2002
77
0.050
Why?
ABO Blood-Group System
1
2002
15
0.050
Why?
Administration, Oral
1
2003
451
0.050
Why?
Thyrotropin
1
2002
49
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
12
0.050
Why?
Drug Interactions
1
2002
205
0.050
Why?
Fatal Outcome
1
2002
196
0.050
Why?
Genomics
1
2023
270
0.050
Why?
Chromosome Mapping
3
2006
155
0.050
Why?
Cell Division
1
2002
291
0.050
Why?
RANK Ligand
1
2022
187
0.040
Why?
Graft Survival
1
2002
160
0.040
Why?
Acute Disease
1
2002
374
0.040
Why?
Cells, Cultured
1
2005
1589
0.040
Why?
Cluster Analysis
3
2006
232
0.040
Why?
Tomography, X-Ray Computed
1
2006
1162
0.040
Why?
Young Adult
3
2015
4319
0.040
Why?
Pain
1
2003
360
0.040
Why?
Neoplasm Transplantation
1
2020
87
0.040
Why?
Depression
1
2005
600
0.040
Why?
Odds Ratio
2
2016
558
0.040
Why?
3' Untranslated Regions
1
2020
55
0.040
Why?
Staphylococcal Infections
1
2003
280
0.040
Why?
Postoperative Complications
1
2007
1066
0.040
Why?
Positron-Emission Tomography
1
2021
303
0.040
Why?
Crystallography, X-Ray
1
2019
156
0.040
Why?
Antigens, CD
2
2015
219
0.040
Why?
Mice, Nude
1
2019
236
0.040
Why?
Protein Conformation
1
2019
179
0.040
Why?
Bone Marrow Cells
2
2015
190
0.040
Why?
Coculture Techniques
2
2012
145
0.040
Why?
Mice, Inbred BALB C
1
2019
312
0.040
Why?
Receptors, Interleukin-6
1
2018
23
0.040
Why?
Antigens, CD19
1
2018
28
0.040
Why?
Microarray Analysis
1
2018
69
0.040
Why?
Drug Resistance
1
2018
65
0.040
Why?
Disease Management
1
2020
188
0.040
Why?
Interferon-gamma
2
2010
179
0.040
Why?
Protein Stability
1
2018
46
0.040
Why?
Gene Knockdown Techniques
1
2018
110
0.040
Why?
Epidemiologic Methods
2
2008
46
0.030
Why?
Aerobiosis
1
2017
13
0.030
Why?
Microfilament Proteins
1
2017
43
0.030
Why?
HLA-A Antigens
2
2007
11
0.030
Why?
Cross-Sectional Studies
1
2022
1676
0.030
Why?
Transplantation, Heterologous
1
2017
79
0.030
Why?
Calcium-Binding Proteins
1
2017
57
0.030
Why?
Thyroid Hormones
1
2017
22
0.030
Why?
Polycomb Repressive Complex 1
1
2016
3
0.030
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2017
53
0.030
Why?
Vaccination
2
2010
297
0.030
Why?
Genetic Loci
1
2016
49
0.030
Why?
Protein Binding
1
2018
680
0.030
Why?
Antibodies, Neoplasm
2
2006
27
0.030
Why?
Mice, Inbred ICR
1
2016
25
0.030
Why?
Microscopy, Electron, Transmission
1
2015
70
0.030
Why?
Mice, Knockout
1
2018
909
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
ras Proteins
1
2015
64
0.030
Why?
Genome-Wide Association Study
1
2016
186
0.030
Why?
Tumor Burden
1
2016
136
0.030
Why?
Repressor Proteins
1
2016
156
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Disease Models, Animal
2
2013
1484
0.030
Why?
Lentivirus
1
2015
17
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
RNA, Messenger
2
2010
1142
0.030
Why?
Models, Biological
1
2018
743
0.030
Why?
Family
1
2016
174
0.030
Why?
Adenine
1
2015
31
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
Molecular Targeted Therapy
1
2016
134
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
9
0.030
Why?
CDC2 Protein Kinase
1
2014
16
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Reactive Oxygen Species
1
2017
425
0.030
Why?
Cell Lineage
1
2014
89
0.030
Why?
Drug Synergism
1
2014
148
0.030
Why?
Mitosis
1
2014
89
0.030
Why?
beta Catenin
1
2015
103
0.030
Why?
Piperidines
1
2015
97
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
136
0.030
Why?
Pyrazoles
1
2015
114
0.030
Why?
Cell Movement
1
2015
277
0.030
Why?
Proportional Hazards Models
2
2006
443
0.030
Why?
Patient Safety
1
2014
104
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, IgG
1
2013
24
0.030
Why?
Chromosomal Instability
1
2013
16
0.030
Why?
Adolescent
2
2014
6692
0.030
Why?
Membrane Glycoproteins
2
2006
244
0.030
Why?
Epitopes
1
2013
65
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
46
0.020
Why?
Protein Kinase Inhibitors
1
2014
230
0.020
Why?
Immunoglobulin M
1
2012
60
0.020
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.020
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.020
Why?
Cytomegalovirus
1
2012
30
0.020
Why?
Viral Load
1
2012
80
0.020
Why?
Interleukin-2
1
2012
69
0.020
Why?
Virus Activation
1
2012
39
0.020
Why?
Peripheral Nervous System Diseases
1
2012
59
0.020
Why?
Immunoenzyme Techniques
1
2012
137
0.020
Why?
Arkansas
2
2008
2028
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Asymptomatic Diseases
1
2011
38
0.020
Why?
Lymphocyte Activation
1
2012
172
0.020
Why?
Protein C
1
2011
20
0.020
Why?
Neoadjuvant Therapy
1
2012
125
0.020
Why?
Chemotherapy, Adjuvant
1
2011
124
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
177
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
Hypersensitivity, Delayed
1
2010
18
0.020
Why?
CD40 Ligand
1
2010
15
0.020
Why?
Interleukin-4
1
2010
44
0.020
Why?
Immunity, Cellular
1
2010
64
0.020
Why?
Adjuvants, Immunologic
1
2010
52
0.020
Why?
Diagnosis, Differential
2
2004
1044
0.020
Why?
Mutation
1
2015
1351
0.020
Why?
Physician's Role
1
2010
50
0.020
Why?
RNA, Small Interfering
1
2010
218
0.020
Why?
Education, Medical, Continuing
1
2010
72
0.020
Why?
Practice Guidelines as Topic
1
2012
487
0.020
Why?
Hyperhomocysteinemia
1
2009
29
0.020
Why?
Indazoles
1
2009
47
0.020
Why?
Protein Isoforms
1
2009
126
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.020
Why?
Safety
1
2009
79
0.020
Why?
Vasculitis
1
2008
30
0.020
Why?
Algorithms
1
2012
668
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Haplotypes
1
2008
94
0.020
Why?
Twins
1
2007
33
0.020
Why?
Double-Blind Method
1
2009
713
0.020
Why?
Age Distribution
1
2007
174
0.020
Why?
C-Reactive Protein
1
2008
155
0.020
Why?
Creatinine
1
2007
149
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Partial Thromboplastin Time
1
2006
13
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Heterozygote
1
2006
91
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Amiloride
1
2005
7
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Proteoglycans
1
2006
87
0.020
Why?
Transduction, Genetic
1
2005
44
0.020
Why?
Cell Line
1
2008
1045
0.020
Why?
Radiography
1
2007
470
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
203
0.020
Why?
Data Interpretation, Statistical
1
2006
164
0.020
Why?
Neoplasms, Experimental
1
2006
113
0.010
Why?
Sensitivity and Specificity
1
2007
879
0.010
Why?
Interferon-alpha
1
2005
52
0.010
Why?
Monocytes
1
2005
130
0.010
Why?
Databases, Factual
1
2007
706
0.010
Why?
Clone Cells
1
2004
77
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
236
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Trisomy
1
2003
35
0.010
Why?
Fibroblasts
1
2005
359
0.010
Why?
History, 21st Century
1
2003
59
0.010
Why?
History, 20th Century
1
2003
96
0.010
Why?
Interphase
1
2003
10
0.010
Why?
Plasmapheresis
1
2003
12
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
United States
1
2013
5182
0.010
Why?
Perforin
1
2002
12
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
11
0.010
Why?
Antigen Presentation
1
2002
26
0.010
Why?
Anemia
1
2003
74
0.010
Why?
Cohort Studies
1
2006
1532
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Prevalence
1
2005
1007
0.010
Why?
Quality Assurance, Health Care
1
2003
149
0.010
Why?
Erythrocyte Transfusion
1
2002
52
0.010
Why?
Cell Culture Techniques
1
2002
99
0.010
Why?
DNA, Neoplasm
1
2002
146
0.010
Why?
Graft Rejection
1
2002
177
0.010
Why?
Kidney Diseases
1
2003
220
0.010
Why?
Anti-Bacterial Agents
1
2003
801
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description